SCHEMBL19642232

SCHEMBL19642232

COc1ccc(C(=O)COC(=O)CC(=O)O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.63
▸ L3MBTL1 Q9Y468 3/20 0.62
▸ HPGD P15428 1/20 0.62
▸ ESR2 Q92731 1/20 0.59
▸ LMNA P02545 1/20 0.58
▸ PDE4B Q07343 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ GSK3B P49841 1/20 0.53
▸ HDAC3 O15379 1/20 0.53
▸ HDAC4 P56524 1/20 0.53
▸ HDAC1 Q13547 1/20 0.53
▸ HDAC7 Q8WUI4 1/20 0.53
▸ HDAC2 Q92769 1/20 0.53
▸ HDAC10 Q969S8 1/20 0.53
▸ HDAC11 Q96DB2 1/20 0.53
▸ HDAC8 Q9BY41 1/20 0.53
▸ HDAC6 Q9UBN7 1/20 0.53
▸ HDAC9 Q9UKV0 1/20 0.53
▸ HDAC5 Q9UQL6 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19642230 0.92 MAPT (0.64) MAPTL3MBTL1HPGDESR2LMNA
SCHEMBL19642671 0.83 KMT2A (0.65) MAPTL3MBTL1HPGDLMNAMEN1
SCHEMBL30074485 0.83 PDE4B (0.72) MAPTL3MBTL1HPGDESR2LMNA
SCHEMBL2427418 0.83 PDE4B (0.66) MAPTLMNAPDE4BKMT2AGSK3B
SCHEMBL9547932 0.81 KMT2A (0.57) MAPTL3MBTL1HPGDESR2LMNA
SCHEMBL28168180 0.81 AGTR1 (0.66) MAPTL3MBTL1HPGDESR2LMNA
SCHEMBL30187377 0.80 ALDH1A1 (0.61) MAPTLMNAMEN1KMT2AHDAC3
SCHEMBL19642632 0.80 KMT2A (0.65) MAPTL3MBTL1HPGDESR2LMNA
SCHEMBL3042221 0.80 ALDH1A1 (0.70) MAPTL3MBTL1HPGDESR2LMNA
SCHEMBL20524447 0.79 ESR2 (0.60) MAPTL3MBTL1HPGDESR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464248-B1 3-OXO-2,6-DIPHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES Bayer Pharma AG (DE) 2021-09-08 — — EP disclosed
EP-3464248-A1 3-OXO-2,6-DIPHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES Bayer Pharma Aktiengesellschaft (DE) 2019-04-10 — — EP disclosed
WO-2017202816-A1 3-OXO-2,6-DIPHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-11-30 — — WO disclosed
Send feedback